malaria

Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem®…

KINSHASA, Congo (AP) — Over 200 health facilities in eastern Congo are experiencing shortages of medicines as a…

New research into the genetics of Anopheles funestus (An. funestus), one of the most neglected but prolific malaria-transmitting mosquitoes…

The report evaluates the direct and indirect economic benefits of US funding for malaria control through two major…

Fox News anchor John Roberts was hospitalized after contracting an uncommon vector-borne disease, according to a People Magazine…

John Roberts has been diagnosed with malaria. The Fox News correspondent was hospitalized with the mosquito-borne disease this…

In a group of health-related headlines, one says “Hope for new drug approach. getty As government-supported research in…

Fox News anchor John Roberts won’t be in his usual seat on weekday afternoons as he battles malaria.…

PIERCE COUNTY, Wash. — The Tacoma-Pierce County Health Department says it’s investigating after a local woman was recently…

Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance